Cargando…
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019
The coronavirus disease 2019 (COVID-19) pandemic has led to the emergence of multiple challenges in the care of patients with systemic rheumatic diseases. Patients with vasculitis represent a group of particular concern due to existing risk factors which include a higher burden of comorbidities and...
Autores principales: | Sattui, Sebastian E., Wallace, Zachary S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011035/ https://www.ncbi.nlm.nih.gov/pubmed/37331741 http://dx.doi.org/10.1016/j.rdc.2023.03.007 |
Ejemplares similares
-
Immunosuppressants: Coronavirus disease-2019: case report
Publicado: (2020) -
Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen
por: Mirjalili, Mahtabalsadat, et al.
Publicado: (2020) -
Immunosuppressants: Coronavirus disease 2019: 4 case reports
Publicado: (2020) -
Corticosteroids/immunosuppressants: Coronavirus disease 2019: case report
Publicado: (2020) -
Immunosuppressants: Coronavirus disease of 2019: 3 case reports
Publicado: (2022)